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1. Introduction 
Arsenic (As) is a naturally occurring ubiquitous element. It is found in the environment in 
the earth crust and quantities in media such as soil, water, rock and air. It is present in the 
environment naturally and due to human activities and other industrial processes such as 
mining and coal-fired power plants. Arsenic has also been used as a pesticide to protect 
animals, wood, fruit and vegetables from insects. Because of its therapeutic properties, 
arsenic has also been used as a medicinal agent. The dark side of the medicine was the 
reputation as an attractive poison 
Arsenic is mainly transported in the environment by food, except in areas with high levels 
of arsenic in the drinking water e.g. India, Taiwan and Bangladesh (2004; Singh, Kumar, and 
Sahu 2007). The outbreak of As was triggered by deep drilled wells and the desire to obtain 
microorganism-free safety drinking water. Arsenic contamination of drinking-water is a 
hazard to human health. Because of the toxicities and side effects of arsenic compounds it is 
known as a major environmental pollutant. The IARC classified arsenic and arsenic 
compounds as a human carcinogen (Group 1) (2004). But although arsenic compounds have 
been known and used for centuries, their mechanisms of interaction in humans are not fully 
elucidated. 
The paradox of arsenic compounds is that, on the one hand, they are considered extremely 
dangerous for human health with acute and chronic adverse health effects. Long-term 
arsenic exposure can lead to several types of cancer. The exposure to As has been associated 
also with non-carcinogenic effects e.g. such diabetes and cardiovascular diseases. On the 
other hand arsenic compounds are regarded as potential drugs against cancer and ranging 
from the use as poisons to applications in semiconductors and pesticides. Especially the 
discovery of organoarsenicals for the treatment of hematological malignancies and solid 
tumor has awakened interest. 
2. Background and basics 
Arsenic is a chemical element in the period table that has the symbol “As”, the atomic number 
33 and an atomic mass of 74,92159 g/ mol. Arsenic exhibits both metallic and non-metallic 
properties. Arsenic exists as unstable oxides and sulfides or as arsenites or arsenates of 
sodium, calcium and potassium. Arsenic has two biologically important oxidation states: 
arsenite (the trivalent form, As III) and arsenate (the pentavalent form, As V). As III is 60 times 
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more toxic than As V (Yousef, El-Demerdash, and Radwan 2008). From biological and 
toxicological view, arsenic compounds can be classified into three major groups: Inorganic 
arsenic compounds, organic arsenic compounds and arsine gas (Hardman et al. 1996). The 
metalloid is found mostly as yellow complex sulfides. Organic arsenic is non-toxic whereas 
inorganic arsenic is toxic. The inorganic forms of arsenic are yellow (AS2S3, orpiment), red  
(AS2S2 realgar) and grey to silver white (FeAsS, arsenopyrite) (Waxman and Anderson 2001). 
 
     a) Orpiment 
 
 b) Realgar 
 
          c) Arsenopyrite 
Fig. 1. Orpiment, realgar and arsenopyrite - from left to right- (Photographs from the Ohio 
State University Newark) 
www.intechopen.com
 Arsenic – Pesticides with an Ambivalent Character 
 
183 
Arsenic compounds have no smell or taste, but heat can cause As to sublimate to gas with a 
distinctive garlic odor (Jones 2007). 
Arsenic naturally occures in the earth´s surface, mostly in inorganic form (Hine, Pinto, and 
Nelson 1977). It exists in low concentrations in many rock types but is frequently associated 
with metal ore deposits e.g. Au (gold) , Ag (silver), Cu (copper) and Fe (iron) (Gochfeld 
1997). The most important natural sources of arsenic in the environment are volcanoes. The 
organic form result when arsenic combines with carbon and hydrogen. 
 
Compound CAS No. Molecular formula 
Arsenic 7440-38-2 As 
Arsenic trioxide 1327-53-3 As2O3 
Arsenic pentoxide 1303-28-2 As2O5 
Arsenic sulphide 1303-33-9 As2S3 
Dimethylarsinic acid (DMA) 75-60-5 (CH3)2AsO(OH) 
Potassium arsenate 7784-41-0 KH2AsO4 
Potassium arsenite 10124-50-2 KasO2HAsO2 
Table 1. Physiochemical properties (1980) 
3. History 
Arsenic and arsenic compounds are known since the ancient times. As early as 500 B.C. the 
ancients knew about arsenic, whose name comes from the Greek word “arsenikon” for 
potent or bold, which means orpiment form Latin auripigmentum. In the 16th an 17th 
centuries, red and white arsenic were put into amulets that were worn around the neck and 
close to the heart to ward off the plaques (Cullen 2008). Most arsenic is found in conjunction 
with sulfur in minerals such as arsenopyrite (AsFeS). Because of the association with ore 
and the stability of As in form like AsFeS, As was used as a “pathfinder element”  in 
geochemical exploration for gold (Jones 2007). 
 
 
Fig. 2. Acidum Arsenicosum Anhydricum bottle, Global Antiques 
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Through the centuries Arsenic was a common method of homicide. The death of the French 
emperor Napoleon Bonaparte, on 5 May 1821 was believed to be a victim after drinking 
arsenic-tainted wine that was served him (Leslie and Smith 1978; Lin, Alber, and 
Henkelmann 2004). Arsenic was a popular murder weapon because of the odorless and 
tasteless properties and the poisoning result in symptoms that can be confused with other 
natural disorders.  In the Middle ages arsenic was a favorite poison and has been called the 
Poison of Kings and the King of Poison (Vahidnia, van, V, and de Wolff 2007). 
Arsenic was also used as healing agents. The Greek physicians such as Hippocrates and 
Galen popularized it use for treating skin ulcers and tumors such as superficial 
epitheliomas. Arsenic has been used as topical pastes, as vapor inhalation, intravenous 
injection, orally in liquid or in solid form. A paste of the sulfides were used for treatment of 
neuralgia, rheumatism, arthritis and skin disease (Shen et al. 1997). Also Fowler´s solution, a 
1% arsenic trioxide preparation, was widely used during the 19th century. Fowler´s original 
recipe was described as “64 grains arsenic oxide, 64 grains purest vegetable alkali, distilled 
water half pound. Heat until clear. Cool. Add half pound spirit of lavender and make up to 
15 oz with water.”  (Cullen 2008). 
 
 
Fig. 3. Fowler´s Solution made by Wisconsin Pharmacal Co 
It was used to treat diseases like leukemia, Hodkin´s disease and pernicious anemia. 
The first organic arsenical used therapeutically was Salvarsan, which was developed by 
Paul Ehrlich 1907. It was used to treat syphilis, until penicillin became available in the 1940s. 




Fig. 4. German 200 Deutschmark banknote with hologram and Paul Ehrlich 
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For centuries arsenic has been used for different purposes. Arsenic was an ingredient of a lot of 
consumer products e.g. wallpapers, toys, food wrappers, cosmetics, pigments in paints – 
known as “Paris green”. William Withering, an english doctor, who discovered 1775 digitalis 
was a proponent of therapies with arsenic. He argued:” Poison in small doses are the best 
medicines; and the best medicines in too large doses are poisonous (Aronson 1994). 
Arsenic-containing compounds have been used for cancer-treatment in both tradition 
Western and Chinese medicine. The first use of arsenic in the treatment of leukemia was in 
1865 by Lissauer (Lissauer and H. 1865). With the development of modern medicine against 
cancer the use of arsenic in the western world diminished. 
4. Epidemiology 
Arsenic exposure occurs from inhalation, absorption through the skin and by ingestion. 
Arsenic is mainly transported in the environment by food, which contains both organic and 
inorganic As, but mostly accrue as relatively no-toxic organic compounds (arsenobentaine 
and arsenocholine). Seafood, fish and algae are the richest organic sources (Edmonds and 
Francesconi 1987). The following table shows an overview of the arsenic content of various 
foods. 
 
Food Estimates of daily intake (µg/d) 
Milk 1,39 
Fruits and vegetable 0,46 
Meat 2,14 





Table 2. Estimated of daily arsenic intake from diet (Sorvari et al. 2007)  
Concentrations of arsenic vary in the environment, e.g. 0,03-025 ppm in soil, 0,023-0,35 ppm 
in plants, up to 55 ppm in groundwater, 0,0001-0,08 ppm in seawater, 4-170 ppm in fish, 
0,008-0,85 ppm in wine and up to 0,00049 or 0,63 mg/ m³ in urban air  (2004; Jones 2007; 
Rahman 2006; Basu et al. 2001). Contamination of arsenic in ground water is a global 
problem and millions of people are at a risk of arsenicosis. People from countries in Asia 
(Taiwan, Bangladesh, West Bengal (India) and South America (Chile and Córdoba) get 
presented to inorganic arsenic in ground water with very high concentration. The arsenic 
poisoning from drinking As-contaminated underground water was often triggered by the 
introduction of deep tube-pump wells to replace surface water. The World health 
organization (WHO) and US environment protection agency (EPA) had set up the standard 
for drinking water known as maximum contamination level (MCL) which is 10 µg/ l 
(Effelsberg 1992). The WHO recommended 0.01 mg/ l of arsenic in drinking water as an 
allowable ranger for human consumption. Millions of people are compelled to use the 
drinking water higher arsenic level than MCL worldwide. In addition there are industrial 
exposures for workers, e.g. semiconductor workers and famers handle with arsenical 
herbicides. Arsenic has been used as feed additives e.g. poultry feeds.  
It was found an increase in the prevalence of skin lesions at 0,005 mg As/ l in the drinking 
water, which is a lower level than the drinking water quality standard of WHO (Yoshida, 
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Yamauchi, and Fan 2004). The skin is very sensitive to As and skin lesions, which are As-
induced, are the early effects to chronic As exposure. 
Arsenic is released to the atmosphere from both natural and anthropogenic sources. 
Tobacco smoke may contain arsenic, especially when the plants have been treated with 
arsenate insecticide. 
 









Table 3. Estimated daily intake of arsenic by the general population ((Devesa et al. 2001; 
Jelinek and Corneliussen 1977; Leblanc et al. 2005; Mohri, Hisanaga, and Ishinishi 1990; 
Saipan and Ruangwises 2009; Sorvari et al., 2007; Watanabe et al. 2004) 
The principal natural source is volcanic activity, with minor contribution by exudates from 
vegetation and wind-blow dust. Man-made emissions to air arise from the smelting of 
metals, the combustion of fuels, especially of low-grade brown coal, and the use of 
pesticides. Because of the use of numerous arsenical pesticides the arsenic concentration 
raised in the soil. 
5. Effects on human 
The biological activity of arsenic in the body covers a broad spectrum from toxic to 
therapeutic agent. Not to forget- Arsenic is a human carcinogen (IARC 2004). A number of 
studies show that arsenic is an essential element for humans. Other studies have attempted 
to show that arsenic has not been demonstrated to be essential to humans (Ohtake 2000).  
The major routes of arsenic absorption in the general population are ingestion and 
inhalation. Meat, fish and poultry account for 80 % of dietary arsenic intake (Edmonds and 
Francesconi 1987). Arsenic is absorbed in the small intestine by an electrogenic process 
involving a proton gradient. The absorbed arsenic undergoes hepatic biomethylation. The 
products are less toxic but not completely innocuous. About 50 % of the ingested dose may 
be eliminated in the urine in 3-5 days. Metabolism of As involves reduction of As V to a 
trivalent state and subsequent oxidative methylation. 
5.1 Acute effects 
After acute poisoning studies show that the highest concentration of arsenic is in the kidney 
and liver (Benramdane et al. 1999). Most cases of acute arsenic poisoning occur from accidental 
ingestion of insecticides or pesticides. Acute exposure to arsenic arise symptoms like 
abdominal pain, vomiting, diarrhea. The abdominal pain may mimic an acute abdomen 
(Mueller and Benowitz 1989). Other clinical features are muscular weakness and cramping, 
erythematous skin eruptions like diffuse skin rash and swelling of acrals. A progressive 
deterioration in the motor and sensory responses and toxic cardiomyopathy may also result 
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leading to shock and death. Depending on the quantity of arsenic, death usually occurs within 
1-5 days. In acute poisoning the best indicator of recent ingestion (1-2 days) is urinary arsenic 
concentration. Dimethylarsinic acid is the dominant urinary metabolite compared with 
monomethylarsoonic acid (Hopenhayn-Rich, Smith, and Goeden 1993). 
5.2 Chronic effects 
Chronic ingestion of inorganic arsenic causes multisystem adverse health effects. The 
clinical features of chronic arsenic toxicity vary between individuals, population groups and 
geographic areas. In chronic arsenic ingestion, arsenic accumulates in the liver, kidneys, 
heart and lungs and smaller amounts in the gastrointestinal tract, spleen and muscles 
(Benramdane et al., 1999). High doses of arsenic cause characteristic skin manifestation, 
vascular, renal and neurological diseases, cardiovascular and chronic lung diseases and 
cancer of skin, lungs, liver, kidney and bladder. After about two weeks arsenic is deposited 
in the hair and nails. Levels between 0,1 and 0,5 mg/ kg on a hair sample indicate chronic 
poisoning. Various epidemiological studies have reported that arsenic exposure is 
associated with hypertension, atherosclerosis and endothelial dysfunction (Yang et al. 2007) 
(Chen et al. 2007) (Kwok et al. 2007). Increasing exposure of arsenic is also associated with 
non insulin dependent diabetes mellitus (Wang et al. 2003). Studies reported that arsenic is 
associated with the growth retardation in children (Wang et al. 2007). 
5.3 Skin symptoms 
Skin manifestation is the most common and initial sign of chronic arsenic exposure. Chronic 
ingestion of arsenic causes characteristic melanosis, keratosis, basal cell carcinoma and 
squamous cell carcinoma (Maloney 1996). Melanosis includes hyperpigmentation, spotted 
pigmentation, depigmentation and leucomelanosis. Keratosis is a late feature of arsenical-
dermatosis and appears especially on palm as a uniform thickening or as discrete nodules 
(Wong, Tan, and Goh 1998b). Both palmar and solar keratosis are significant diagnostic 
criterion. Bowen´s disease is a precancerous lesion and predisposed to an increased 
incidence of the squamous cell carcinoma. Chronic ingestion of arsenic lead to accumulate in 
keratin rich areas of body and appears as white lines in the nails, called Mee´s lines (Fincher 
and Koerker 1987). The latency period of skin lesions of arsenic after first exposure varies 
 
 
Fig. 5. Patient with plantar keratosis (2004; Wong, Tan, and Goh 1998c).  
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Fig. 6. Blackfoot diseases after chronic arsenic exposure (Better Life Laboratories, USA) 
from 20 to 50 years (Haque et al. 2003). It is described that the latent period after exposure 
can be as long as 60 years, which has been reported in patients treated with Fowler´s 
solution, in vineyard workers using arsenical pesticides and from drinking contaminated 
wine (Everall and Dowd 1978). 
Many different systems within the body are affected by chronic exposure. Some of these 
systems and their associated toxic effects from chronic arsenic exposure are listed in the 
following table.  
 
System Effect and symptoms 
Skin Skin lesions (melanosis, keratosis) 
Cardiovascular Blackfoot disease, atherosclerosis, hypertension 
Hepatic Hepatomegaly, fibrosis, cirrhosis, altered heme metabolism 
Hematological Bone marrow depression (anemia, leucopenia, 
thrombocytopenia)  
Endocrine  Diabetes 
Renal Tubule degeneration, papillary and cortical necrosis 
Nervous Peripher and central neuropathy, encephalopathy 
respiratory Pulmonary insufficiency, emphysem 
Gastrointestinal Hemorrhage 
Table 4. Human effects after chronic arsenic exposure (Singh, Kumar, and Sahu 2007; 
Schuhmacher-Wolz et al. 2009; Hughes 2002; Balakumar and Kaur 2009; Rahman, Ng, and 
Naidu 2009). 
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Arsenic compounds or arsenic-containing compounds vary in toxicity to mammalian cells. 
Arsenic does not directly react with DNA or cause gene mutations, except to a small extent 
at high dose. As can cause gene amplification and chromosomal damage at lower doses and 
can enhance mutagenesis by other agents, apparently by inhibiting DNA repair. The 
following table gives an overview over the modes of carcinogenic action of arsenic. 
 
Modes of carcinogenic action of arsenic 
Genotoxicity 
Oxidative damage 
Modification of cell signalling 
Influence on DNA repair  
Influence on DNA methylation 
Changes in cell proliferation 
Co-mutagenesis and transformation 
Tumor promotion 
Table 5. Modes of carcinogenic action of arsenic (Schuhmacher-Wolz, Dieter, Klein, and 
Schneider 2009; Hughes 2002).  
The binding with sulfhydryl groups by arsenite compounds has the potential to influence a 
wide range of metabolic activities. Arsenic toxicity inactivates up to 200 enzymes. The 
effects of As occur through indirect alteration of gene expression via disruption of DNA 
methylation, inhibition of DNA repair, oxidative stress, or altered modulation of signal 
transduction pathways. Another indirect mechanism is the influence of growth-stimulating 
chemicals or cytokinesed generated in response to arsenic exposure. Biotranformation is the 
major metabolic pathway for inorganic arsenic in humans. Toxic inorganic arsenic species 
can be biomethylated by bacteria, algae, fungi and humans. The high affinity of arsenic for 
sulphydryl groups makes keratin-rich cells a target for arsenic. 
The order of toxicity of arsenicals is: 
Monomethylarsonic acid (MMA III) > Arsenite (III) > Arsenate (V) > MMA(V) (Singh, 
Kumar, and Sahu 2007). 
In arsenic biotransformation the intermediate product MMA III is highly toxic than other 
arsenical, which might be responsible for the arsenic-induced carcinogenesis and other 
effects (Styblo et al. 2000). As III binds thiol or sulfhydryl groups in tissue proteins of the 
liver, lungs, kidney, spleen, gastrointestinal mucosa and keratin-rich-issues (skin, hair, 
nails). By binding a wide range of metabolic activities are influenced including cellular 
glucose uptake, gluconeogenesis and fatty acid oxidation (Jones 2007). Many other toxic 
effects of arsenic compounds are detailed by Abernathy et al in 1999 (Abernathy et al. 1999).  
The acute toxicity is related to its chemical form and oxidation state. In the human adult the 
lethal range of inorganic arsenic is estimated at a dose of 1-3 mg As /  kg (Schoolmeester and 
White 1980). The characteristics of acute arsenic toxicity in humans include gastrointestinal 
discomfort, vomiting, diarrhea, bloody urine, anuria, shock, convulsions, coma and death. 
7. Pharmaceutical use 
Arsenic has been used therapeutically for over 2000 years. During the 18th- 20th centuries 
arsenic compounds have been used as medicines, including arsphenamine and arsenic 
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trioxide. In 1910, Paul Ehrlich introduced the arsenic-based drug Salvarsan (arsenobenzol) 
as a remedy for syphilis in all stages, a sexually transmitted disease. It was efficient in 
various similar diseases such as relapsing fever, Vincent´ s angina. 
Arsenic trioxide is also known as an anti-bacterial and anti-cancer agent (Bardos, tta-Gupta, 
and Hebborn 1966). Inorganic As has been also used pharmacologically for the treatment of 
eczema, pemphigus and psoriasis under the name of Fowler´s solution. It was a 1 % solution 
of potassium arsenite, colored with a tincture of lavender-which contained a very high 
concentration of arsenic (Rahman 2006). Some arsenic containing drugs are still presently 
used to treat diseases like asthma rheumatism, cough, pruritus and itching (Ko 1999; Wong, 
Tan, and Goh 1998a). 
In 2000, the US Food and Drug Administration approved the use of arsenic trioxide for 
treatment of relapsed or refractory acute promyelocytic leukemia (APL), a subtype of acute 
myeloid leukemia (AML) (Antman 2001). It is based on its mechanism as an inducer of 
apoptosis (programmed cell death) (Soignet et al. 1998).  
 
 
Fig. 7. Effects of all-trans-retinoic acid and arsenic trioxide in the blast cells of acute 
promyelocytic leukemia (APL)  (Look 1998). 
Traditional medicine products contain arsenic sulfides (realgar) and are available as pills 
and tablets. They are still used for psoriasis, syphilis, asthma, rheumatism, hemorrhoids, 
cough and pruritus and are rescribed as a health tonic, an analgesic, anti-inflammatory 
agent (Ko 1999; Wong, Tan, and Goh 1998d). In Korea arsenic is prescribed in herbal 
medicine for anal suffering such haemorrhoids (Mitchell-Heggs, Conway, and Cassar 1990). 
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8. Industrial use 
In industry, arsenic is used to manufacture polants, fungicides, insecticides, pesticides, 
herbicides, wood preservatives, and cotton desiccants. 
In most local hardware stores arsenic-containing herbicides are readily available, the most 
common are e.g. Disodium methylarsonate (DSMO), monosodium methylarsonate (MSMA), 
monomethyl arsenic acid (MMA(V)). These compounds can kill crabgrass and other 
unwanted grass types. Arsenic trioxide (AS2O3) is commonly used as an antisecticide. 
Arsenic acid and arsenous acid are common rodenticides. The major use for arsenic is in the 
form of chromated copper arsenate, which reduces termites and ants from wood. 
Arsenic is used industrially as an additive to glass to reduce coloring, in semiconductors, in 
pigments such as Paris green (CuHAsO3) and in pesticides. Paris Green is a common name 
for copper (II) acetoarsenite, which is a toxic emerald-green crystalline powder. Other 
names for the chemical are Emerald Green, Vienna Green, Schweinfurt Green and Parrot 
Green. The use has been abandoned around 1960. The III-V semiconductors are very 




Fig. 8. Paris Green bottle 
(http:/ / theodoregray.com/ periodictable/ Elements/ 033/ index.s7.html). 
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9. Arsenic, wine and profession 
Arsenic was used in vineyards for only some years as a pesticide. It was officially 
introduced as a pesticide in viniculture in 1925. Its purpose was to protect the wine plants. 
But it was banned in 1942. It was used in Germany until the mid 1950ties (Shab, 2009). 
Consumption of the so-called wine-grower´s house drink led to severe symptoms and 
illnesses, especially liver damage. This homemade wine was produced by watering down 
the wine obtained from a second pressing of the grape skins. It was consumed in large 
quantities, which had a low alcohol content, from 3-5 %, but high arsenic content (Kunz and 
Kunz 2008). Exposure to arsenic has been reported to lead to cirrhosis and to angiosarcoma 
among famers exposed to arsenical insecticides. Chronic liver disease which can be caused 
by arsenic toxicity includes also steatosis and noncirrhotic portal hypertension (Von Hyman 
J.Zimmerman. 1999).   
Not only at the vineyards there was an occupational exposure to arsenic. Other important 
occupational exposure opportunities exist for processing of metal ores, roasting of pyrites in 
the chemical industry, the production and use of arsenic colors and tints for glass, porcelain 
and ceramics industry, pesticides and wood preservatives as well as at the battery and 
semiconductor. Occupational diseases caused by arsenic and its compound can be 
recognized as an occupational disease (BK-Nr. 1108 in Germany) (1964).  
  
 
Fig. 9. Wine glass with wine yard (Markus Ebert - photographer Heidelberg/ Potsdam) 
10. Conclusion 
From history to the present, the story of arsenic is double-edged: a poisonous edge and a 
medicinal edge. Arsenic has been mentioned mainly as a poison and public health problem 
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than as an effective anticancer drug. Arsenic is one of the most toxic metals derived from the 
natural environment. Inorganic Arsenic is a human carcinogen, but nowadays also acts as a 
beneficial chemotherapeutic agent. The major cause of human arsenic toxicity is from 
contamination of drinking water and from As-contaminated food through fertilization. 
Current uses of arsenic compounds are in the glass industry, as a wood preservative and in 
the production of semiconductor. Over the centuries, arsenic has been used for a variety of 
purposes. In industry arsenic is used as a potential weapon against insecticides concerning 
humans as a modern weapon. Arsenic compounds became available e.g. in Fowler´s 
solution as indication for skin conditions and treatment for acute and chronic diseases. 
Arsenic affects many cellular and physiological pathways, which is useful in treating 
malignancies like hematological cancer and solid tumors. The ability of arsenic trioxide to 
treat APL has changed the point of view. 
Still today moderately elevated concentrations of inorganic arsenic in drinking water is a 
major public health concern as well as arsenic exposure from food, especially rice products 
(Sun et al. 2008). 
Chronic arsenicism may lead to multiple benign skin diseases as well as potentially fatal 
skin and visceral malignancies e.g. lungs, bladder, liver kidneys. Pigmentation changes and 
hyperkeratosis are the earliest signs of toxicity from chronic exposure. People with chronic 
arsenicism should undergo regular skin and systemic examination. There are no evidence 
based treatments to reduce chronic arsenic poisoning, but antioxidants have been 
advocated: Pharmacological interventions such as vitamin C, folic acid, vitamin b12 have 
been identified to halt the development of arsenic-induced toxicity. More studies are 
needed. The essential and basic efforts for the reduction of chronic arsenic toxicity are 
prevention. Although current exposure to arsenic is decreasing, continual surveillance 
programs to detect unrestricted and unsupervised manufacture and sale of drugs that may 
contain inorganic arsenic must be implemented to prevent a potentially fatal disorder. 
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